Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Dec. 15, 2010 /- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Clinical...

Pharmaceutical Institute Hires Nathan Pienkowski, Ph.D., to Head Instructional Design

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Dec. 15, 2010 /- Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, has appointed Nathan Pienkowski, Ph.D., as Instructional Design Director.  In this role,...

Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee

December 15, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J., Dec. 15, 2010 /- Johnson & Johnson (NYSE: JNJ ) today announced that Alex Gorsky, currently Worldwide Chairman, Medical Devices & Diagnostics (MD&D) and Sheri McCoy, currently Worldwide Chairman, Pharmaceuticals, have been appointed Vice Chairmen of the...

Advertisement

NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance

December 15, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Dec. 15, 2010 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced that NASDAQ has given the company until June 13, 2011, to comply with its $1 per share minimum bid rule. "Given the challenges of the general economy, we welcome the grant by NASDAQ of an additional...

DSM Expands Industrial Biocatalysis Platform With c-LEcta Agreement

December 14, 2010 10:34 pm | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. and LEIPZIG, Germany, Dec. 15 2010 /- DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology. The agreement grants DSM rights to c-LEcta's proprietary...

UBM Canon Launches Medical Manufacturing Events in India and Brazil

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Dec. 14, 2010 /- UBM Canon today announced medical manufacturing event plans for two fast-growth BRIC markets, India and Brazil, utilizing respectively its long established MEDTEC and Medical Design & Manufacturing (MD&M) brands. In October 19-20, 2011, the MEDTEC...

Verenium Announces 2010 Business Update and Outlook for 2011

December 14, 2010 6:39 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Dec. 14, 2010 /- Verenium Corporation (Nasdaq: VRNM ), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced key 2010 accomplishments and 2011 Company goals and financial guidance. "2010 has been a significant...

Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility

December 14, 2010 12:39 am | by Bio-Medicine.Org | News | Comments

COLORADO SPRINGS, Colo., Dec. 14, 2010 /- Cannabis Science, Inc. (OTC Bulletin Board: CBIS ) a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce it has signed a lease for a new corporate headquarters as its new base of operations in...

Advertisement

Natural Orifice Surgery Introduced to Relieve Acid Reflux

December 13, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 13, 2010 /PRNewswire-USNewswire/ -- Montefiore Medical Center has introduced a natural orifice surgery through the mouth, to relieve gastroesophageal reflux disease (GERD), most commonly known as acid reflux. Since this natural orifice transluminal endoscopic surgery...

iLeverage Announces the Successful Sale of the BICO Patent Portfolio for Near-Infrared Non-Invasive Blood Analytes Measurement

December 13, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO, Dec. 13, 2010 /- iLeverage ( www.ilvrge.com ), a leading patent broker, today announced the successful closing of the Biocontrol patent portfolio sale. The patents were offered to companies that participate in the relevant markets as well as to a number of IP licensing...

Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine

December 12, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 12, 2010 /- Pfizer Inc. (NYSE: PFE ) announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of...

SABCS 2010: Interview with C. Kent Osborne, M.D.(2)

December 11, 2010 5:35 pm | by AACR | News | Comments

Dr. Osborne talks about the most compelling research presented at the symposium this year, his long association with the SABCS and his vision for its future.

SABCS 2010: Interview with Eric P. Winer, M.D.

December 11, 2010 12:31 pm | by AACR | News | Comments

SABCS 2010: Interview with Eric P. Winer, M.D., director of the Breast Oncology Center and Thompson senior investigator in breast cancer research at Dana-Farber Cancer Institute; professor of Medicine at Harvard Medical School Dr. Winer discusses breast cancer screening, the clinical...

Advertisement

SABCS 2010: Interview with Robert E. Coleman, M.D.

December 11, 2010 10:31 am | by AACR | News | Comments

Dr. Coleman, chief investigator of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial, presents the rationale for studying the bisphosphonate zoledronic acid, and the final results of this study.

SABCS 2010: Interview with Paul Workman, Ph.D., F.Med.Sci.

December 11, 2010 6:37 am | by AACR | News | Comments

Dr. Workman defines molecular chaperones and discusses their role in the cell, stress response pathways, heat shock proteins and the potential of this line of breast cancer research.

SABCS 2010: Interview with Rowan T. Chlebowski, M.D. Ph.D.

December 11, 2010 6:36 am | by AACR | News | Comments

Dr. Chlebowski, lead investigator for the Women's Health Initiative, discusses the initiative's findings about the use of hormone therapy and its influence on cancer incidence and related cancer mortality, and the effects of bisphosphonates on breast cancer risk.

SABCS 2010: Interview with Laura Esserman, M.D., M.B.A.

December 11, 2010 6:36 am | by AACR | News | Comments

Dr. Esserman discusses her philosophy of holistic treatment and involving patients in the decision-making process, a cancer risk tracking system, and the I-Spy trials that match treatments to patients based on biomarkers.

SABCS 2010: Interview with Klaus Pantel, M.D., Ph.D.

December 11, 2010 6:36 am | by AACR | News | Comments

Dr. Pantel discusses his findings about micrometastasis that contradict long-held beliefs about metastasis, and the implications of these discoveries for the treatment of breast cancer.

SABCS 2010: Interview with Edith A. Perez, M.D.

December 11, 2010 6:35 am | by AACR | News | Comments

In this podcast, Dr. Perez discusses ALTTO (the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), the role of genetic markers in breast cancer treatment, the challenges of treating patients with triple-negative breast cancer, and the promise of personalized medicine.

SABCS 2010: Interview with Charles M. Perou, Ph.D.

December 11, 2010 6:35 am | by AACR | News | Comments

Dr. Perou talks about genomic and genetic approaches to characterizing diverse breast cancers and their unique biologic features, using next-generation sequencing, and the implications of this science for clinical use.

SABCS 2010: Interview with Rochelle Shoretz

December 11, 2010 6:35 am | by AACR | News | Comments

Ms. Shoretz talks about the mission of Sharsheret, how she came to establish this nonprofit organization, and her appointment to a federal advisory committee on breast cancer in young women.

SABCS 2010: Interview with Sandi Stanford

December 11, 2010 6:34 am | by AACR | News | Comments

Ms. Stanford talks about the mission of the Alamo Breast Cancer Foundation and how advocates can take an active role in breast cancer research.

SABCS 2010: HER2 Teleconference

December 11, 2010 5:34 am | by AACR | News | Comments

Neil Spector, M.D., professor of medicine at Duke University Medical Center, hosts this press conference.

SABCS 2010: Circulating Tumor Cells and Metastasis Teleconference

December 11, 2010 5:34 am | by AACR | News | Comments

Minetta Liu, M.D., director of translational breast cancer research at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, hosts this press conference.

Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand

December 10, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., Dec. 10, 2010 /- Managing multiple brands for the same indication is a complex balancing act for bio-pharmaceutical companies. While a new product can translate into expanded market share and improved reputation with physicians, it can also result in a new product...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading